• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of a novel cancer immunotherapy using the artificial proteins consisted in the functional peptide motifs.

Research Project

Project/Area Number 22650231
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeSingle-year Grants
Research Field Tumor immunology
Research InstitutionJikei University School of Medicine

Principal Investigator

ITO Masaki  東京慈恵会医科大学, 医学部, 助教 (80297366)

Co-Investigator(Kenkyū-buntansha) HOMMA Sadamu  東京慈恵会医科大学, 医学部, 准教授 (50192323)
KOIDO Shigeo  東京慈恵会医科大学, 医学部, 准教授 (70266617)
Co-Investigator(Renkei-kenkyūsha) SHIBA Kiyotaka  がん研究所, 蛋白創製研究部, 部長 (40196415)
Project Period (FY) 2010 – 2011
Project Status Completed (Fiscal Year 2011)
Budget Amount *help
¥3,190,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥390,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2010: ¥1,500,000 (Direct Cost: ¥1,500,000)
Keywords人工タンパク質 / MolCraft / 細胞性免疫 / OVA / 樹状細胞 / 腫瘍免疫 / 液性免疫 / がん / 腫瘍免疫療法 / 人工蛋白質 / 免疫 / WT1
Research Abstract

We have constructed an artificial protein library by combinatorially assembling four peptide motifs associated with the MHC class I epitope and MHC class II epitope of OVA(Ovalbumin), alpha-helical motif and randomized peptide sequence, respectively. We have generated two artificial proteins, F37A and F182A, which have the ability to induce OVA-specific cellular immunity without using any adjuvant. These exogenous proteins presented OVA-specific MHC class I epitope through the cross-presentation pathway in the antigen presenting cells. Our studies have demonstrated that the motif-programmed artificial proteins might be able to induce cellular immunity contribute to cancer immunotherapy.

Report

(3 results)
  • 2011 Annual Research Report   Final Research Report ( PDF )
  • 2010 Annual Research Report
  • Research Products

    (16 results)

All 2012 2011 2010 Other

All Journal Article (10 results) (of which Peer Reviewed: 10 results) Presentation (4 results) Remarks (2 results)

  • [Journal Article] Gemcitabine enhances Wilms' tumor gene Immunotherapy synergizes with chemotherapy targeting pancreatic cancer2012

    • Author(s)
      Koido S., Homma S., Ito M., et al.
    • Journal Title

      Immunotherpy

      Volume: 4 Issue: 1 Pages: 5-7

    • DOI

      10.2217/imt.11.150

    • Related Report
      2011 Annual Research Report 2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Current immunotherapeutic approaches in pancreatic cancer2011

    • Author(s)
      Koido S., Homma S., Ito M., et al.
    • Journal Title

      Clin Dev Immunol

      Volume: 267539 Pages: 1-15

    • DOI

      10.1155/2011/267539

    • Related Report
      2011 Annual Research Report 2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Immunologic monitoring of cellular responses by Dendritic/Tumor cell fusion vaccines2011

    • Author(s)
      Koido S., Homma S., Ito M., et al.
    • Journal Title

      Journal of Biomedicine and Biotechnology

      Volume: 910836 Issue: 1 Pages: 1-14

    • DOI

      10.1155/2011/910836

    • Related Report
      2011 Annual Research Report 2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response2011

    • Author(s)
      Takahara A, et al
    • Journal Title

      Cancer Immunol Immunother

      Volume: 60(9) Issue: 9 Pages: 1289-97

    • DOI

      10.1007/s00262-011-1033-3

    • Related Report
      2011 Annual Research Report 2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] The identification of a novel Paneth cell-associated antigen in a familial adenomatous polyposis mouse model2010

    • Author(s)
      Ito M, Suzuki H, Sagawa Y, Homma S
    • Journal Title

      Biochemical and Biophysical Research Communications

      Volume: 400 Issue: 3 Pages: 548-553

    • DOI

      10.1016/j.bbrc.2010.06.096

    • Related Report
      2011 Final Research Report 2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Regulation of tumor immunity by tumor/dendritic cell fusions2010

    • Author(s)
      Koido S, Homma S, Hara E, Namiki Y, Takahara A, Komita H, Nagasaki E, Ito M, Ohkusa T, Gong J, Tajiri H
    • Journal Title

      Clin Dev Immnol

      Volume: 51678

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Dendritic/pancreatic carcinoma fusions for clinical use : Comparative functional analysis of helthy-versus patient-derived fusions2010

    • Author(s)
      Koido S, Hara E, Homma S, Namiki Y, Komita H
    • Journal Title

      Clin Immunol.

      Volume: 135(3) Pages: 384-400

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Accumulation of functional regulatory T cells in actively inflamed liver in mouse dendritic cell-based autoimmune hepatic inflammation2010

    • Author(s)
      Saeki C, Homma S, et al.
    • Journal Title

      Clin Immunol.

      Volume: 135 Pages: 156-166

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical use2010

    • Author(s)
      Gong J, Koido S, et al.
    • Journal Title

      J Immunol.

      Volume: 184 Pages: 488-496

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Combined treatment with dendritic cells and 5-fluorouracil elicits augmented NK cell-mediated antitumor activity through the tumor necrosis factor-alpha pathway2010

    • Author(s)
      Nagasaki E, Takahara A, Koido S, Sagawa Y, Aiba K, Tajiri H, Yagita H, Homma S
    • Journal Title

      J Immunother.

      Volume: 33(5) Pages: 467-74

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Presentation] Study of photodynamic diagnosis of colon cancer generated in DSS(Dextran sulfate sodium) utilizing Apc(Adenomatous polyposis Coli) knockout mice by visualization following oral 5-aminolevulinic acid sensitization2012

    • Author(s)
      Komoike A, Homma S, Ito M, et al
    • Organizer
      DDW Digestive Disease Weeks
    • Place of Presentation
      San Diego, CA USA
    • Year and Date
      2012-05-20
    • Related Report
      2011 Final Research Report
  • [Presentation] iPS細胞から腫瘍血管を標的とした癌ワクチンの開発2011

    • Author(s)
      本間定、佐川由紀子、伊藤正紀、永崎栄次郎、高原映崇、込田英夫、小井戸薫雄
    • Organizer
      第70回日本癌学会学術総会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-03
    • Related Report
      2011 Final Research Report
  • [Presentation] iPS細胞から腫瘍血管を標的とした癌ワクチンの作製2011

    • Author(s)
      本間定、佐川由紀子、伊藤正紀、永崎栄次郎、高原映崇、込田英夫、小井戸薫雄
    • Organizer
      第15回日本がん免疫学会総会
    • Place of Presentation
      大阪
    • Year and Date
      2011-07-01
    • Related Report
      2011 Final Research Report
  • [Presentation] 抗腫瘍免疫反応により産生されるインターフェロンガンマはゲムシタビン活性化酵素の発現を上昇させる2010

    • Author(s)
      本間定、佐川由紀子、高原映崇、永崎栄次郎、込田英夫、伊藤正紀、小井戸薫雄
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪
    • Year and Date
      2010-09-24
    • Related Report
      2011 Final Research Report
  • [Remarks]

    • URL

      http://www.jikei.ac.jp/academic/course/17_akuseisyuyo.html

    • Related Report
      2011 Final Research Report
  • [Remarks]

    • URL

      http://www.jikei.ac.jp/academic/course/17_akuseisyuyo.html

    • Related Report
      2011 Annual Research Report

URL: 

Published: 2010-08-23   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi